Antinuclear antibodies as potential markers of lung cancer

Clinical Cancer Research

Volumn 5, Issue 6, 1999, Pages 1393-1400

  Fernández Madrid, Félix ^a,c   VandeVord, Pamela J ^a   Yang, Xin ^a   Karvonen, Robert L ^a   Simpson, Pippa M ^b,d   Kraut, Michael J ^a   Granda, José L ^a   Tomkiel, John E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^c HUTZEL HOSPITAL   (United States)

^d CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; TUMOR MARKER;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNITY; CANCER DIAGNOSIS; CELLULAR IMMUNITY; CONNECTIVE TISSUE DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LUNG CANCER; MALE; PRIORITY JOURNAL; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; CELL LINE; DISEASE-FREE SURVIVAL; FEMALE; HELA CELLS; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0345280046     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Abelev, G. I., Perova, D. S., Kheamkova, N. I., Posnikova, Z. A., and Irlin, I. S. Production of embryonal α globulin by transplantable mouse hepatomas. Transplantation, 1: 174-180, 1963.
2. Day, E. A. The Immunochemistry of Cancer. Springfield, IL: C. C. Thomas, 1965.
3. Gold, P., and Freedman, S. O. Specific carcinoembryonic antigens of the human digestive system. J. Exp. Med., 122: 467-481, 1965.
4. Knuth, A., Danowski, B., Oettgen, H. F., and Old, L. J. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures. Proc. Nat. Acad. Sci. USA, 81: 3511-3515, 1984.
5. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
6. Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L., and Boon, T. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics, 35: 145-152, 1992.
7. Rettig, W. J., and Old, L. J. Immunogenetics of human cell surface differentiation. Annu. Rev. Immunol., 7: 481-511, 1989.
8. Graus, F., Elkon, K. B., Cordon-Cardo, C., and Posner, J. B. Sensory neuronopathy and small cell lung cancer: antineuronal antibody that also reacts with the tumor. Am. J. Med., 80: 45-52, 1986.
9. Anderson, N. E., Rosenblum, M. K., Graus, F., Wiley, R. G., and Posner, J. B. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology, 38: 1391-1398, 1988.
10. Kimmel, D. W., O'Neill, B. P., and Lennon, V. A. Subacute sensory neuronopathy associated with small cell lung carcinoma: diagnosis aided by autoimmune serology. Mayo Clin. Proc., 63: 29-32, 1988.
11. Dalmau, J., Graus, F., Rosenblum, M. K., and Posner, J. B. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine (Baltimore), 71: 59-72, 1992.
12. 2 phase cells. Biochem. Biophys. Res. Commun., 207: 1029-1037, 1995.
13. Bravo, R., Fey, S. J., Bellatin, J., Larsen, P. M., Arevalo, J., and Cells, J. E. Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation. Exp. Cell Res., 136: 311-319, 1981.
14. Bravo, R., and Celis, J. E. Human proteins sensitive to neoplaslic transformation in cultured epithelial and fibroblast cells. Clin. Chem., 28: 949-954, 1982.
15. McCarty, G. A. Autoimmunity and malignancy. Med. Clin. North Am., 69: 599-615, 1985.
16. Swissa, M., Amital-Teplizki, H., Haim, N., Cohen, Y., and Shoenfeld, Y. Autoantibodies in neoplasia: an unresolved enigma. Cancer (Phila.), 65: 2554-2558, 1990.
17. Tan, E. M. Antibody markers in systemic autoimmunity. In: K. D. Brandt (ed.), Diagnostic Studies in Rheumatology. Summit, NJ: Ciba Geigy, 1992.
18. von Mühlen, C. A., and Tan, E. M. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin. Arthritis Rheum., 24: 323-358, 1995.
19. Tan, E. M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol., 44: 93-151, 1989.
20. Fernandez-Madrid, F., and Mattioli, M. Antinuclear antibodies (ANA): immunologic and clinical significance. Semin. Arthritis Rheum., 6: 83-124, 1976.
21. Moore, A. E., Sabachewsky, L., and Toolan, H. W. Culture characteristics of four permanent lines of human cancer cells. Cancer Res., 15: 598-602, 1955.
22. Rothfield, N. F. Detection of antibodies to nuclear antigens by immunofluorescence. In: N. R. Rose and H. Friedman (eds.), Manual of Clinical Immunology, pp. 647-651. Washington, DC: American Society of Microbiology, 1976.
23. Howqua, J., and Mackay, I. R. LE cells in lymphoma. Blood, 22: 191-198, 1963.
24. Whitehouse, J. M., and Holborow, E. J. Smooth muscle antibody in malignant disease. Br. Med. J., 4: 511-513, 1971.
25. Burnham, T. K. Antinuclear antibodies in patients with malignancies. Lancet, 2: 436-437, 1972.
26. Hamilton-Fairley, G. Autoantibodies in malignant disease. Br. J. Haematol., 23 (Suppl.): 231-234, 1972.
27. Ablin, R. J. Malignancy associated with antinuclear antibodies. Lancet, 2: 1253-1254, 1972.
28. Steiner, M., Klein, E., and Klein, G. Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases. Clin. Immunol. Immunopathol., 4: 374-381, 1975.
29. Hodson, M. E., and Turner-Warwick, M. Autoantibodies in patients with bronchial carcinoma. Thorax, 30: 367-370, 1975.
30. Lamelin, J. P., de-The, G., Revillard, J. P., and Gabbiani, G. Autoantibodies (cold lymphocytotoxins, antiactin antibodies and anti-nuclear factors) in nasopharyngeal carcinoma patients. IARC Sci. Pub., 523-536, 1978.
31. Osman, J., Regan, R. J., and Dathan, J. R. Bilateral renal carcinoma with metastasis in gall bladder and associated with a strongly positive ANA. Br. J. Urol., 50: 212-212, 1978.
32. Bentwich, Z., Talpaz, M., and Schechter, D. Antinuclear antibodies (ANA) in the sera of carcinoma patients: increased incidence with dissemination of the disease. Proc. Am. Assoc. Cancer Res./Am. Soc. Clin. Oncol., 20: 154, 1979.
33. Marcus, R. M., and Grayzel, A. I. A lupus antibody syndrome associated with hypernephroma. Arthritis Rheum., 22: 1396-1398, 1979.
34. Salem, N. B. Lupus antibody syndrome with intestinal lymphoma. Arthritis Rheum., 23: 613-614, 1980.
35. Chen, Y-M., Hu, C-P., Chen, P-H., Chu, M-H. H., Tsai, Y-T., Lee, S-D., and Chang, C. Nuclear antigens reacted with sera ascites of hepatocellular carcinoma patients. Hepatology, 8: 547-552, 1988.
36. Budde-Steffen, C., Anderson, N. E., Rosenblum, M. K., and Posner, J. B. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy. Cancer Res., 48: 430-434, 1988.
37. Freundlich, B., Makover, D., and Maul, G. G. A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome. Ann. Intern. Med., 109: 295-297, 1988.
38. Takimoto, T., Ishikawa, S., Masuda, K., Tanaka, S., Yoshizaki, T., and Umeda, R. Antinuclear antibodies in the sera of patients with nasopharyngeal carcinoma. Am. J. Otolaryngol., 10: 399-403, 1989.
39. Smith, P., Rice, M., Ricci, N., Toogood, I., and Roberton, D. A case of Burkitt's lymphoma presenting with digital ischaemia. Acta Paediatr., 82: 217-219, 1993.
40. Doutre, M. S., Beylot, J., Beylot, C., Abs, L., and Lacoste, D. Systemic lupus erythematosus and Hodgkin's disease. Int. J. Dermatol., 33: 436-437, 1994.
41. Fernández-Madrid, F., Karvonen, R. L., Kraut, M. J., Czelusniak, B., and Ager, J. W. Autoimmunity to collagen in human lung cancer. Cancer Res., 56: 121-126, 1996.
42. Wood, E. R., and Earnshaw, W. C. Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II. J. Cell Biol., 111: 2839-2850, 1990.
43. Laemli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lend.), 227: 680-685, 1970.
44. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Nat. Acad. Sci. USA, 76: 4350-4354, 1979.
45. Breiman, L., Friedman, J. H., Olshen, R. A., and Stone, C. J. Classification, and Regression Trees. Belmont, CA: Wadsworth, 1984.
46. Clark, L. A., and Pregibon, D. Tree-based models. In: J. M. Chambers and T. J. Haste (eds.), Statistical Models in S. Pacific Grove, CA: Wadsworth, 1992.
47. Steinberg, D., and Phillip, C. CART: Tree-Structured Non-Parametric Data Analysis. San Diego, CA: Salford Systems, 1995.
48. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
49. Fry, W. A., Menck, H. R., and Winchester, D. P. The National Cancer Data Base report on lung cancer. Cancer (Phila.), 77: 1947-1955, 1996.
50. Imai, H., Ochs, R. L., Kiyosawa, K., Furuta, S., Nakamura, R. M., and Tan, E. M. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am. J. Pathol., 140: 859-870, 1992.
51. Imai, H., Nakano, Y., Kiyosawa, K., and Tan, E. M. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer (Phila.), 71: 26-35, 1993.
52. Burek, G. L., and Rose, N. R. Autoantibodies. In. R. B. Collins, H. K. Bhan, and R. T. McCluskey (eds.), Diagnostic Immunopathology, pp. 207-230. New York: Raven Press Limited, 1995.
53. Hecht, S. S. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit. Rev. Toxicol., 26: 163-181, 1996.
54. Sardas, S., Walker, D., Akyol, D., and Karakaya, A. E. Assessment of smoking-induced DNA damage in lymphocytes of smoking mothers of newborn infants using the alkaline single-cell gel electrophoresis technique. Mutat. Res., 335: 213-217, 1995.
55. Petruzzelli, S., Tavanti, L. M., Celi, A., and Giuntini, C. Detection of N7-methyldeoxyguanosine adducts in human pulmonary alveolar cells. Am. J. Respir. Cell Mol. Biol., 15: 216-223, 1996.
56. Pulera, N., Petruzzelli, S., Celi, A., Puntoni, R., Fornai, E., Sawe, U., Paoletti, P., and Giuntini, C. Presence and persistence of serum anti-benzo[a]pyrene diolepoxide-DNA adduct antibodies in smokers: effects of smoking reduction and cessation. Int. J. Cancer, 70: 145-149, 1997.
57. Ebert, W., Muley, T., and Drings, P. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Anticancer Res., 16: 2161-2168, 1996.
58. Sahin, U., Türeci, O., Schmitt, H., Cochlovius, B., Johannes, T., Schmits, R., Stenner, F., Luo, G., Schobert, I., and Pfreundschuh, M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Nat. Acad. Sci. USA, 92: 11810-11813, 1995.
59. Türeci, O., Sahin, U., and Pfreundschuh, M. Serological analysis of human tumor antigens: molecular definition and implications. Mol. Med. Today, 3: 342-349, 1997.
60. Sahin, U., Türeci, O., and Pfreundschuh, M. Serological identification of human tumor antigens. Curr. Opin. Immunol., 9: 709-716, 1997.
61. Old, L. J., and Chen, Y-T. New paths in human cancer serology. J. Exp. Med., 187: 1163-1167, 1998.
62. Jäger, E., Chen, Y. T., Drijfhout, J. W., Karbach, J., Ringhoffer, M., Jager, D., Arand, M., Wada, H., Noguchi, Y., Stockert, E., Old, L. J., and Knuth, A. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med., 187: 265-270, 1998.